Status:

COMPLETED

Acute Effects of Added Sugar Intake on Cerebrovascular Function and Brain Integrity

Lead Sponsor:

University of Delaware

Conditions:

Healthy Diet

Healthy Aging

Eligibility:

All Genders

30-64 years

Phase:

NA

Brief Summary

This study will focus on acute effects of added sugars on brain health in a specific age group (30-64 years old). We will provide participants two meals (one meal containing 16 g of added sugars and t...

Detailed Description

Cardiometabolic risk factors are strongly influenced by lifestyle-related environmental factors including the consumption of an unhealthy Western diet (WD). Added sugars (i.e., caloric sweeteners adde...

Eligibility Criteria

Inclusion

  • Ability to provide informed consent;
  • Men and women within the ages of 30-64 years;
  • Habitual added sugar intake of \<150 kcal/day for men and \<100kcal/day for women;
  • No allergies/intolerance to ingredients in the study meal (e.g., nuts, gluten)

Exclusion

  • Blood chemistries indicative of abnormal liver enzymes and renal function;
  • Abnormal blood chemistry marker that is +/-2.5x the upper or lower limit;
  • Chronic clinical diseases (e.g., coronary artery, peripheral artery, or cerebrovascular diseases, diabetes (type 1 and type 2), stages 5-6 chronic kidney disease, chronic obstructive pulmonary disease);
  • Major psychiatric disorder (e.g. schizophrenia, bipolar disorder, major depression within past two years);
  • Neurological or autoimmune conditions affecting cognition (e.g. Parkinson's disease, epilepsy, multiple sclerosis, head trauma with loss of consciousness greater than 30 min, large vessel infarct);
  • Current medication use likely to affect central nervous system functions (e.g. long active benzodiazepines) and lipid-lowering medications (e.g., statins)
  • Conditions which would contra-indicate MRI: implant of pacemakers or pacemaker wires; artificial heart valve; brain aneurysm surgery; middle ear implant; non-removable hearing aid or jewelry; braces; cataract surgery or lens implant; implanted mechanical or electrical device; foreign metallic objects in the body such as bullets, BBs, shrapnel, or metalwork fragments, claustrophobia;
  • Current smoking;
  • Pregnancy or breastfeeding

Key Trial Info

Start Date :

June 14 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 17 2023

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT05408338

Start Date

June 14 2022

End Date

April 17 2023

Last Update

May 10 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Delaware

Newark, Delaware, United States, 19713